Salmonella Testing and Treatment Market expected to reach USD 3.032 billion by 2030

Salmonella Testing and Treatment Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the salmonella testing and treatment market will expand from USD 2.236 billion in 2025 to USD 3.032 billion in 2030 at a CAGR of 6.28% during the forecast period.

The rising incidences of salmonella outbreaks are causing an increasing number of diseases among people, such as foodborne illnesses and typhoid fever, among others, driving the need for diagnosis and treatment for humans. It is also driving the demand for diagnosis and treatment in animals such as poultry and other animals, as they also spread the disease. The increasing number of Salmonella outbreaks is prompting the need to stop the spread and ensure public health safety. This growing concern has led governments to take stricter actions, implementing regulations and investing in testing and treatment solutions, leading to market growth. Further, there is an increasing focus on food safety, as it is critical to preventing the spread of Salmonella and its outbreak. Moreover, the advancement in diagnostic techniques for testing and treatment is greatly boosting market growth.

Salmonella Testing and Treatment Market Report Highlights

• The market is driven by a growing Salmonella outbreak, rising government regulations and the growing consumer awareness about the importance of safe food.
• The antibiotic treatment segment will continue dominating the Salmonella treatment market share. Common antibiotics like Ciprofloxacin, Azithromycin, Ampicillin, and others are used for severe Salmonella infections.
• During the forecast period, Asia-Pacific will be the fastest-growing region. Meanwhile, North America will continue dominating the market in the coming years. Europe will also have a significant market share in the forecast period.
• Asia-Pacific is driven by the growing economies like China, South Korea, and India, which are driving continued healthcare infrastructure development. This is propelling the need for Salmonella testing and treatment.

Report Coverage:

Report Metric	Details
Salmonella Testing and Treatment Market Size in 2025	US$2.236 billion
Salmonella Testing and Treatment Market Size in 2030	US$3.032 billion
Growth Rate	CAGR of 6.28%
Drivers	Rising government regulations Increasing number of Salmonella outbreaks
Restraints	High Cost Antibiotic Resistance
Segmentation	Testing Method Treatment Method End-User Geography
List of Major Companies in Salmonella Testing and Treatment Market	Pfizer Inc. Agilent Technologies Inc. Eurofins Scientific QIAGEN Bio-Rad Laboratories Inc.

Salmonella Testing and Treatment Market Drivers and Restraints

Growth Drivers:

• Rising government regulations: There are increasing government regulations worldwide for food manufacturers for salmonella testing their food products, such as dairy products, processed foods, etc., before being sold to the market. This regulation is increasingly being tightened due to the rising number of Salmonella outbreaks, necessitating the government to take stricter regulatory and preventive measures in the food and beverage industry to effectively test food products before they are sold to the public.
• Increasing number of Salmonella outbreaks: An increasing number of Salmonella outbreaks have been witnessed in recent years, primarily due to contamination in poultry, meats, foods, and beverages, which are then transmitted to people. There are 9.4 million cases of foodborne illness, a disease caused by the Salmonella bacteria, and 1,351 deaths due to foodborne illness.

Restraints:

• High Cost: The Salmonella testing and treatment are highly costly due to the use of advanced testing techniques such as PCR, generation sequencing and others. This becomes one of the key challenges for the market adoption as it becomes price-sensitive in key regions such as developing countries and underdeveloped countries.
• Antibiotic Resistance: Rising antibiotic resistance is also a key factor that is a key challenge to the market. Increasing misuse and overuse have led to the development of drug-resistant Salmonella strains. This makes the treatment less effective and raises healthcare costs.

Salmonella Testing and Treatment Market Developments

• Product Launch: In August 2025, Bio-Rad Launches EZ-Check Salmonella spp. Kit for Detection of Salmonella spp. in Food and Environmental Samples. It features multiplex amplification of the target pathogen and an internal control to prevent false negatives, while the duplex detection system enhances accuracy and simplifies reaction set up.
• Product Launch: In January 2025, Neogen Corporation launched the new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96). This kit integrates qualitative pathogen testing solutions and Quantitative Rapid Enrichment Dehydrated (QRED) media designed to enable controlled growth rates for quantitation.

Salmonella Testing and Treatment Market Segmentation

Knowledge Sourcing Intelligence has segmented the Salmonella Testing and Treatment Market based on testing method, treatment method, end-user and region: Salmonella Testing and Treatment Market, By Testing Method

• Culture-based Methods
• Molecular-based Methods
• Immunoassay

Salmonella Testing and Treatment Market, By Treatment Method

• Antibiotic Treatment
• Supportive Care
• Vaccination
• Others

Salmonella Testing and Treatment Market, By End-User

• Food Industry
• Healthcare
• Agriculture and Animal Husbandry
• Others

Salmonella Testing and Treatment Market, By Region

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others
• South America
  • Brazil
  • Argentina
  • Others
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • Others

Salmonella Testing and Treatment Market Key Players

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Gold Standard Diagnostics
• Romer Labs
• BD
• Pfizer Inc.
• Agilent Technologies Inc.
• Eurofins Scientific
• QIAGEN
• Bio-Rad Laboratories Inc.